Health Care: Drugs

Protalix BioTherapeutics Inc (PLX: AMEX)

$1.95 n/a | n/a%
12/19/14 - 04:01 PM ET
Company Profile
Price and Volume
Recent Price 1.95
52 Week High 5.30
52 Week Low 1.86
Avg. Daily Vol. (Mil) 0.37
Beta (3 year) 0.24
Share Related Items
Mkt Cap (Mil) 182.66
Shares Out (Mil) 93.67
Float (Mil) 78.67
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.60
Current Ratio 2.90
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 12.26
Price/Book 0.00
Price/Cash Flow -6.40
Per Share Data
Earnings -0.35
Sales 0.16
Book Value 0.00
Cash Flow -0.31
Business Summary
Protalix BioTherapeutics, Inc. is a biopharmaceutical company engaged in the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system.
General Information
2 Snunit Street
Science Park
Carmiel, 20100
www.protalix.com
Industry : Drugs
Sector: Health Care
Employees: 260
CEO: Moshe Manor
Short Interest
Current Month (Mil) 6.10
Previous Month (Mil) 5.96
Short Interest Ratio (Days) 17.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -38.20
Return on Investments -164.60
Profitability
Gross Margin 64.30
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with PLX

Latest PLX Headlines from TheStreet

More Financial News for PLX

Press Releases for PLX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter